Volume 86, Issue 1
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645



Secondary bacterial infections are a major complication and cause of death in children with visceral Leishmaniasis (VL). Thus, early diagnosis of bacterial infections is an important step in the treatment of patients with VL. The goal of this study was to determine if serum procalcitonin (PCT) could be used as a diagnostic marker of secondary bacterial infections in VL patients. Serum PCT was measured in 35 hospitalized patients with VL before treatment and after defervescence. The level was higher than normal (> 0.5 ng/mL) in 72% (25) of the patients. Twelve (34%) of 35 patients had secondary bacterial infections with PCT levels ranging from 0.1 to 12.29 ng/mL, and those without secondary bacterial infections (23) had PCT levels ranging from 0.1 to 14.58 ng/mL. The results suggest that PCT levels increase significantly in most VL patients but are not correlated with the presence of secondary bacterial infections.


Article metrics loading...

Loading full text...

Full text loading...



  1. Alborzi A, Rasouli M, Shamsizadeh A, , 2006. Leishmania tropica-isolated patient with visceral leishmaniasis in southern Iran. Am J Trop Med Hyg 74: 306307.
  2. Moslehi MA, Kadivar MR, , 2008. Visceral leishmaniasis in pediatrics: a study of 367 cases in southwest Iran. Trop Doct 38: 186188.[Crossref]
  3. Kadivar MR, Kajbaf TZ, Karimi A, Alborzi A, , 2000. Childhood visceral leishmaniasis complicated by bacterial infections. East Mediterr Health J 6: 879882.
  4. Maruna P, Nedělníková K, Gürlich R, , 2000. Physiology and genetics of procalcitonin. Physiol Res 49: S57S61.
  5. Aikawa N, Fujishima S, Endo S, Sekine I, Kogawa K, Yamamoto Y, Kushimoto S, Yukioka H, Kato N, Totsuka K, Kikuchi K, Ikeda T, Ikeda K, Harada K, Satomura S, , 2005. Multicenter prospective study of procalcitonin as an indicator of sepsis. J Infect Chemother 11: 152159.[Crossref]
  6. Assicot M, Gendrel D, Carsin H, Raymond J, Guilbaud J, Bohoun C, , 1993. High serum procalcitonin concentrations in patients with sepsis and infection. Lancet 341: 515518.[Crossref]
  7. Schüttrumpf S, Binder L, Hagemann T, Berkovic D, Trümper L, Binder C, , 2003. Procalcitonin: a useful discriminator between febrile conditions of different origin in hemato-oncological patients. Ann Hematol 82: 98103.
  8. Brunkhorst R, Eberhart OK, Haubitz M, Brunkhorst FM, , 2000. Procalcitoin for discrimination between activity of systemic autoimmune disease and systemic bacterial infection. Intensive Care Med 26: S199S201.[Crossref]
  9. Gendrel D, Bohuon C, , 2000. Procalcitonin in pediatrics for differentiation of bacterial and viral infections. Intensive Care Med 26: S178S181.[Crossref]
  10. Chiesa C, Pacifico L, Mancuso G, Panero A, , 1998. Procalcitonin in pediatrics: overview and challenge. Infection 26: 236241.[Crossref]
  11. Prat C, Domínguez J, Rodrigo C, Giménez M, Azuara M, Jiménez O, Galí N, Ausina V, , 2003. Elevated serum procalcitonin values correlate with renal scarring in children with urinary tract infection. Pediatr Infect Dis J 22: 438442.
  12. Prat C, Domínguez J, Rodrigo C, Giménez M, Azuara M, Jiménez O, Galí N, Ausina V, , 2003. Procalcitonin, C-reactive protein and leukocyte count in children with lower respiratory tract infection. Pediatr Infect Dis J 22: 963967.[Crossref]
  13. Chiwakat CB, Manegold C, Bönicke L, Waase I, Jülch C, Dietrich M, , 2001. Procalcitonin as a parameter of disease severity and risk of mortality in patients with Plasmodium falciparum malaria. J Infect Dis 183: 11611164.[Crossref]
  14. Karimi A, Alborzi I, Mahmoodi MR, Rakhshani AH, Kadivar MR, , 1998. Short course anti-Leishmania therapy in children with visceral leishmaniasis. Iran J Med Sci 23: 610.

Data & Media loading...

  • Received : 07 Feb 2011
  • Accepted : 21 Sep 2011

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error